Risk Factors for Geographic Atrophy After Intravitreal Ranibizumab Injections for Retinal Angiomatous Proliferation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk Factors for Geographic Atrophy After Intravitreal Ranibizumab Injections for Retinal Angiomatous Proliferation

Published:2015-02 Issue:2 Volume:159 Page:285-292.e1
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Cho Han Joo,Yoo Seul Gi^ORCID,Kim Hyoung Seok,Kim Jae Hui,Kim Chul Gu,Lee Tae Gon^ORCID,Kim Jong Woo

Publisher

Elsevier BV

Subject

Ophthalmology

Reference30 articles.

1. Retinal angiomatous proliferation in age-related macular degeneration;Yannuzzi;Retina,2001

2. Clinical characteristics of exudative age-related macular degeneration in Japanese patients;Maruko;Am J Ophthalmol,2007

3. Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration;Cohen;Br J Ophthalmol,2007

4. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results;Gharbiya;Retina,2009

5. Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration;Atmani;Eye (Lond),2010

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inter-Reader and Inter-Modality Variability in Macular Atrophy Quantification in Neovascular AMD: Comparison of Six Imaging Modalities.;Ophthalmology Retina;2024-08

2. Effect of Pro Re Nata Regimen with Anti-VEGF on Type 3 Macular Neovascularization: Long-Term Outcomes;Ophthalmic Research;2024-04-15

3. Assistance Burden Comparison Between Age-Related Macular Degeneration and Retinal Angiomatous Proliferation Over a Three-Year Follow-up;Ophthalmic Surgery, Lasers and Imaging Retina;2024-04

4. Long term follow up of patients with MNV3 treated with intra-vitreal Aflibercept;European Journal of Ophthalmology;2024-02-02

5. Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3